Report
Erdem Hafizoglu
EUR 103.41 For Business Accounts Only

BGC Partners: SELCUK ECZA 1Q19 - Better

Selcuk Ecza reported a net income of TL253.3mn in 1Q19 (+66.6%, y/y), better (consensus: TL195mn, BGC: TL193mn)… There was a 26.4% rise in pharmaceuticals prices (EUR adjustment) in February 2019; the rise in prices helped Selcuk Ecza to post strong margins in 1Q19, thanks to growing top line and inventory gains (we expect the impact to fade significantly in 2Q19). Revenues of TL4,163mn in 1Q19 (+26.8%, y/y) were in line with estimates (consensus: TL4,184mn, BGC: TL4,171mn), but the company posted TL279.6mn EBITDA in the quarter at an impressive 6.7% margin, exceeding market estimates (consensus: TL228mn, 5.5% margin, BGC: TL224mn, 5.4% margin).
Provider
BGC Partners
BGC Partners

BGC has been one of the major market players in Turkish OTC debt, FX and swaps markets since 1998.

We started offering corporate finance and investment banking services to our clients in 2013. We offer a complete range of financial services to help our clients achieve their goals. Our main areas of activity within investment banking are as follows:

  • Mergers & Acquisitions
  • Equity Capital Markets
  • Debt Finance & Advisory

Analysts
Erdem Hafizoglu

Other Reports from BGC Partners

ResearchPool Subscriptions

Get the most out of your insights

Get in touch